HOME >> BIOLOGY >> NEWS
Gene expression profiling aids in ovarian cancer prognosis

BOSTON -- The identification of a gene expression profile using microarray technology may help clinicians better determine the prognosis of patients with advanced stage ovarian cancer and may eventually help provide targeted therapies for this hard-to-treat disease, according to a study led by investigators at Beth Israel Deaconess Medical Center (BIDMC).

The findings, described in an advance on-line publication of the December issue of the Journal of Clinical Oncology, represent the first time that this type of genetic test has proven useful as a prognostic tool for ovarian cancer, which accounts for approximately 26,000 new cases and 16,000 deaths in the United States each year.

"Ovarian cancer is widely recognized as being extremely difficult to treat," explains Stephen A. Cannistra, M.D., Director of Gynecologic Medical Oncology at BIDMC and Associate Professor of Medicine at Harvard Medical School. "Because symptoms often do not appear until the disease has already spread to the upper abdomen, this malignancy is usually not diagnosed until it has reached an advanced stage." At that point, he adds, doctors typically use clinical data such as the amount of residual disease remaining following surgery to assess a patient's prognosis and determine their course of therapy, a method that Cannistra notes is admittedly imperfect.

Knowing that the behavior of cancers is partly dependent upon which genes are turned on and off in tumor cells, researchers have long suspected that a better understanding of the genetic profile of the tumors of individual patients could help in making a more accurate prognosis.

"With the advent of microarray analysis -- in which genes expressed by the cancer cells are labeled with a probe and then applied to a glass slide that contains embedded sequences of thousands of known human genes this type of genetic information has become much more accessible," explains Cannistra. "[Throug
'"/>

Contact: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center
18-Nov-2004


Page: 1 2 3

Related biology news :

1. A low expression of MX2 gene exists in the white blood cells of narcoleptics
2. Gene expression pattern could lead to improved treatment of pediatric septic shock
3. Boston Univeristy bioengineers devise dimmer swith to regulate gene expression in mammal cells
4. Clocking in and out of gene expression
5. High cholesterol diets modify gene expression in atherosclerosis
6. Gene expression patterns predict rapid decline in idiopathic pulmonary fibrosis patients
7. Decoding gene expression in cancer tumors using noninvasive imaging
8. Growing nerve cells in 3-D dramatically affects gene expression
9. XDx to present recent success with AlloMap molecular expression testing
10. Fat tissue-derived hormone leptin increases e-cadherin expression, obesity-breast cancer link noted
11. Clues to gene expression in cystic fibrosis will guide research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/16/2018)... POWAY, Calif. (PRWEB) , ... October 16, 2018 , ... ... taken to look for a possible tumor and instead, Sam’s veterinarian found that he ... not experiencing any obvious discomfort, so his owner placed him on supplements for the ...
(Date:10/16/2018)... ... October 15, 2018 , ... Modality Solutions, ... regulated industries, is a silver sponsor and exhibitor at the Executive Platforms’ Biomanufacturing ... The Biomanufacturing World Summit brings together the “who’s who” of pharmaceutical executives, cutting-edge ...
(Date:10/16/2018)... Utah and BOSTON (PRWEB) , ... ... ... CallTower , a global leader in delivering cloud-based enterprise-class unified communications and ... Boost delivers enhanced network stability by directly connecting CallTower data centers to ...
Breaking Biology News(10 mins):
(Date:10/3/2018)... (PRWEB) , ... October 03, 2018 , ... Milwaukee Area ... open house Wednesday, Oct. 17, from 3-7 p.m. in Room T129 in the T ... to its new CNC Swiss Lab. A ribbon cutting and formal program will be ...
(Date:10/2/2018)... ... 2018 , ... The Alliance for Clinical Research Excellence and ... standards and testing of procedures for voluntary accreditation of clinical research sites. The ... Quality Management Systems and Chief Quality Officer, is underway in association with ...
(Date:9/27/2018)... ... September 26, 2018 , ... ... Melina Cimler, a senior quality, regulatory, and in vitro diagnostic device expert with ... diagnostic industry has joined the firm as an Expert Consultant. Her experience includes ...
(Date:9/27/2018)... ... September 27, 2018 , ... ... Everwell Health Solutions and SureAdhere Mobile Technology, Inc. announced they will formally merge ... in the battle against tuberculosis (TB) and other diseases. These two social enterprise ...
Breaking Biology Technology:
Cached News: